Module 2: H2RA Flashcards

1
Q

True or False: Histamine H2 receptor antagonists are primarily used to treat allergic reactions.

A

False.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Multiple Choice: Which of the following is NOT a common indication for histamine H2 receptor antagonists? A) Zollinger-Ellison syndrome B) Allergic rhinitis C) Duodenal ulcers D) Gastroesophageal reflux disease

A

B) Allergic rhinitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are common indications for famotidine 10 - 20 mg po

A

Self-medication of acid ingestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are common indications for famotidine 20 or 40mg PO

A

Duodenal ulcer - tx/prophylaxis

Benign gastric ulcer - Tx

GERD - Tx and maintenance of remission

Gastric hyper-secretion - tx (e.g. Zollinger-Ellison Syndrome = a digestive disorder causing overproduction of acid in the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are common indications for Ranitidine 75, 150mg

A

Self-medication of acid indigestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are common indications for Ranitidine high doses/prescription?

A

Duodenal ulcer - treatment/prophylaxis

Benign gastric ulcer – treatment

Gastric ulcer prophylaxis

GERD – treatment

Acid aspiration syndrome – prophylaxis

Hemorrhage from stress ulceration or recurrent bleeding - prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical outcomes/treatment goals of histamine H2 receptor antagonists?

A

Inhibited gastric acid secretion

Tx of acute bleeding in the upper GI tract = acid suppression promotes coagulation and platelet aggregation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the mechanism of action of histamine H2 receptor antagonists.

A

Compete with histamine for reversible binding with H2 receptors on stomach parietal cells

They reversibly inhibit the cAMP-dependent activation of H+, K+-ATPase (the proton pump) that pumps hydrogen ions into the gastric lumen.

H2Ras reduce the basal, nocturnal and stimulated gastric acid secretion in proportion to dose with less effect on stimulated secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the pharmacokinetic considerations of taking Histamine H2 Receptor Antagonists?

A

A: Rapidly absorbed orally with bioavailability 40-70%. Ranitidine undergoes first pass metabolism. IM dose of ranitidine rapidly and almost completely absorbed.

D: Low plasma protein binding: 15-20% for famotidine, 10-19% for ranitidine.

M: Famotidine = 30-35% metabolized to an active metabolite. Ranitidine = 70% excreted unchanged in urine; metabolites may be active

E: Mainly excreted in urine; metabolites may be active.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

True or False: Histamine H2 receptor antagonists must be taken with food.

A

False: Taken without regard to meals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are pediatric considerations for H2 receptor antagonsis?

A

Increased risk for development of acute gastroenteritis and community-acquired pneumonia. Routine use in neonates associated with increased mortality and risk of infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Can H2 receptor antagonists be taken in pregnancy and during lactation?

A

Yes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the pharmacologic category of famotidine and ranitadine?

A

Histamine-2 (H2) receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Can famotidine and ranitidine be taken with renal impairment?

A

Famotidine: CrCl<50ml/min: Administer 50% of usual dose or continue with regular dose and interval at every 36-48 hours.

Ranitidine: CrCl<50ml/min: Decrease dose by 50%. 150mg q24Hr recommended.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Can famotidine and ranitidine be taken with hepatic impairment?

A

Yes.

Child-Turgotte-Pugh Class A-C: IV, Oral: no dosage adjustment necessary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are common significant adverse reactions associated with famotidine and ranitidine?

A

CNS: agitation, confusion, delirium (>60 and liver and kidney impairment increases chances)

Necrotizing enterocolitis in VLBW neonates

Cardiac effects and can cause prolonged QT.

17
Q

What is the concern with Vit B12 and H2 receptor antagonists?

A

H2 receptor antagonists can reduce absorption of vitB12, thus decresing serum levels.

18
Q

What are common expected side effects of H2 receptor antagonists?

A

Headache (up to 17%)

Somnolence (state of drowsiness or strong desire to sleep) (up to 2%)

Dizziness (up to 5%)

Nausea, vomiting, constipation and diarrhea (1-2%)

19
Q

What are 2 general drug interaction considerations for H2 receptor antagonists?

A

Reduced absorption of drugs requiring gastric acidity.

H2RAs are substrates for P-glycoprotein in vitro (use P-glycoprotein transporter for absorption, excretion and other activities which can lead to change sin the effects of other drugs on the body)

20
Q

What are 2 ranitidine specific drug interaction considerations?

A

Ranitidine - can increase drug levels by competing for renal tubular secretion.

Ranitidine inhibits CYP2D6 and 3A but d/t weaker binding, interactions are rare.

21
Q

What are the risks to long-term gastric acidity inhibition?

A

May enhance the survival of ingested organisms = increase risk for infection.
- H2RAs assoc with 50% increase risk for C. Diff (lower risk than with PPI)
- Increased risk of community and hospital-acquired pneumonia

Rebound increase in basal and stimulated gastric secretion may begin within 24 hours after d/c of 4 weeks of chronic therapy.

22
Q

Treatment with H2RAs could mask what underlying causes?

A

CVD or GI malignancy

23
Q

How quickly does tachyphylaxis (acute tolerance) occur with H2RA’s?

A

2 days - 2 weeks after first dose. Manifests as loss of acid inhibitory efficacy.

24
Q

What are some monitoring parameters with H2RA use?

A

Liver enzymes

Occult blood with GI bleeding, S&S of peptic ulcer disease

When used for stress-related GI bleeding - measure the intragastric pH and try to maintain pH >4

When used for Zollinger-Ellison syndrome, monitor gastric acid secretion (goal: <10mEq/hour)

Renal function

Sexual function in men taking high doses

CBC

25
Q

What is onset of action and duration for Famotidine?

A

Onset of Action:
Oral- within 1 hour

Peak effect: Oral - within 1- 3 hrs (dose-dependent); IV - within 30 mins

Duration: IV, Oral - 10-12 hours

26
Q

What is the peak and half-life for ranitidine?

A

Peak: 2-3 hours

Half-life: 2-3 hours

27
Q

What are general parameters for monitoring protocols with GI related meds?

A

Establish comprehensive monitoring protocols for renal function, electrolyte levels, and cognitive effects is essential, with dosage adjustments made to optimize treatment and minimize risk.